ELVN (ELVN) Stock Price & Analysis
ELVN (ELVN) rose 0.00% to USD 52.95 as of July 25, 2026 at 02:24 UTC, according to Nexqual real-time market data.
ELVN last closed at USD 52.95; the session ranged USD 51.83–53.71 on volume of 332,408 shares. Market capitalization is —, with a 52-week range of USD 14.79–54.88 (NMS). Source: Nexqual, July 25, 2026 at 02:24 UTC.
Key Statistics (as of July 25, 2026 at 02:24 UTC)
| Price | USD 52.95 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 52.95 |
| Open | USD 52.95 |
| Day Range | USD 51.83 – 53.71 |
| 52-Week Range | USD 14.79 – 54.88 |
| Volume | 332,408 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ELVN)
Nexqual's technical model rates ELVN "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 02:24 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 64.28 (neutral) |
| vs SMA50 | Above (USD 45.32) |
| MACD | 2.18 (positive) |
From ELVN's Latest SEC 10-K Filing (filed 2026-03-03)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | USD 40.84 | ▲ 6.55% |
| SYRE | Spyre Therapeutics, Inc. | USD 102.13 | ▲ 2.98% |
| MLYS | Mineralys Therapeutics, Inc. | USD 26.71 | ▼ 1.11% |
| DNTH | Dianthus Therapeutics, Inc. | USD 103.87 | ▲ 1.08% |
| TYRA | Tyra Biosciences, Inc. | USD 30.63 | ▲ 0.13% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:24 UTC. This page is informational and not investment advice.